The system approach to the introduction of new medical technologies in hematology

Abstract


The system analysis of the stages of the introduction of new medical technologies into practical public health based on the example of the introduction of the technology of the cord blood bank in the Samara region is carried out. The determination of the economic benefit of this technology is carried out. The necessary stages for the successful introduction of any new medical technology are proposed.

Full Text

Системный подход внедрения новых медицинских технологий в гематологии

About the authors

O V Tyumina


References

  1. Владимирская Е.Б. Дифференцированные потенции стволовых гемопоэтических клеток / Е.Б. Владимирская, А.Г. Румянцев// Вопросы гематологии/онкологии и иммунопатологии в педиатрии.- 2002.- № 1.- С. 7-11.; Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.// Lancet. -2010.- Vol.11(7).- P.653-660.
  2. Gluckman E., Broxmeyer H.E., Auerbach A.D. et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord from an HLA - identical sibling // N. Engl. J. Med.- 1989.- Vol.321.- P.1184-1178.
  3. Ashfaq K, Yahaya I, Hyde C, Andronis L,et al. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.//Health Technol Assess.- 2010.- 14(54).- P.11-30.
  4. Koreth J, Schlenk R, Kopecky KJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.// JAMA.- 2009.- Vol.301(22).-P.2349-2361.
  5. Atsuta Y, Suzuki R, Nagamura-Inoue T et al. Disease-specific analyses of unrelated cord blood transplantation with acute leukemia compared with unrelated bone marrow transplantation in adult patients. //Blood.- 2009.- Vol.113.- P.1631-1638.
  6. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.// Lancet. -2010.- Vol.11(7).- P.653-660.
  7. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.// Blood.- 2001.- Vol.97.- P.2962–2971.
  8. Ashfaq K, Yahaya I, Hyde C, Andronis L,et al. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.//Health Technol Assess.- 2010.- 14(54).- P.11-30.
  9. Atsuta Y, Suzuki R, Nagamura-Inoue T et al. Disease-specific analyses of unrelated cord blood transplantation with acute leukemia compared with unrelated bone marrow transplantation in adult patients. //Blood.- 2009.- Vol.113.- P.1631-1638.
  10. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.// Lancet. -2010.- Vol.11(7).- P.653-660.
  11. Koreth J, Schlenk R, Kopecky KJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.// JAMA.- 2009.- Vol.301(22).-P.2349-2361.
  12. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.// Blood.- 2001.- Vol.97.- P.2962–2971.
  13. Howard D, Maiers M, Kollman C, et al. A cost-benefit analysis of increasing cord blood inventory levels / Cord blood. // Washington DC.- 2005. –P.221-241.; Kollman C, Esteban A, Baitty T, et al. Assessment of optimal size and composition of the U.S. national registry of hematopoietic stem cell donors.// Transplantation. – 2004.-Vol.78(1) – P. 89-95.
  14. Kollman C, Esteban A, Baitty T, et al. Assessment of optimal size and composition of the U.S. national registry of hematopoietic stem cell donors.// Transplantation. – 2004.-Vol.78(1) – P. 89-95.
  15. Чисов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2009 году.// М.: АН ТИФ, 2010. 186 с.; По данным www.//gks.ru
  16. Howard D, Maiers M, Kollman C, et al. A cost-benefit analysis of increasing cord blood inventory levels / Cord blood. // Washington DC.- 2005. –P.221-241.
  17. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.// Blood.- 2001.- Vol.97.- P.2962–2971.
  18. http://www.minzdravsoc.ru
  19. http://minzdravsoc.samregion.ru
  20. www.//gks.ru
  21. Ягудина Р.И., Куликов А.Ю., Нгуен Т.Определение «порога готовности платить» в России, в Европейских странах и в странах СНГ. // Фармакоэкономика. – 2011. - №1.- с.7-11.

Statistics

Views

Abstract - 22

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2011 Tyumina O.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies